Shares of Johnson & Johnson
JNJ,
+0.26%
inched 0.26% higher to $165.11 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index
SPX,
-0.80%
falling 0.80% to 3,665.78 and Dow Jones Industrial Average
DJIA,
-0.30%
falling 0.30% to 30,333.59. The stock’s rise snapped a two-day losing streak. Johnson & Johnson closed $21.58 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert.
RHHVF,
+0.89%
rose 0.89% to $325.78, Merck & Co. Inc.
MRK,
-0.34%
fell 0.34% to $92.94, and Pfizer Inc.
PFE,
-0.46%
fell 0.46% to $42.91. Trading volume (5.7 M) remained 1.9 million below its 50-day average volume of 7.5 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
